The Gross Margin of Hikma Pharmaceuticals PLC (HIK.L) is 45.88%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 45.88% |
| 2023-12-31 | 48.94% |
| 2022-12-31 | 50.26% |
| 2021-12-31 | 50.96% |
| 2020-12-31 | 51.82% |
| 2019-12-31 | 49.70% |
| 2018-12-31 | 51.64% |
| 2017-12-31 | 50.26% |
| 2016-12-31 | 52.21% |
| 2015-12-31 | 56.81% |